CAS
Cue Advisory Services’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-30,178
| Closed | -$1.79M | – | 93 |
|
|
2018
Q3 | $1.79M | Sell |
30,178
-100
| -0.3% | -$5.95K | 1.08% | 27 |
|
|
2018
Q2 | $1.66M | Sell |
30,278
-270
| -0.9% | -$14.8K | 1.01% | 30 |
|
|
2018
Q1 | $1.5M | Sell |
30,548
-3,140
| -9% | -$155K | 0.99% | 27 |
|
|
2017
Q4 | $1.59M | Sell |
33,688
-3,604
| -10% | -$170K | 1.04% | 27 |
|
|
2017
Q3 | $1.86M | Buy |
37,292
+1,135
| +3% | +$56.7K | 1.29% | 19 |
|
|
2017
Q2 | $1.65M | Buy |
36,157
+2,273
| +7% | +$104K | 1.19% | 23 |
|
|
2017
Q1 | $1.43M | Buy |
33,884
+5,357
| +19% | +$227K | 1.08% | 24 |
|
|
2016
Q4 | $1.11M | Sell |
28,527
-2,375
| -8% | -$92.2K | 0.9% | 33 |
|
|
2016
Q3 | $1.3M | Sell |
30,902
-4,213
| -12% | -$177K | 1.09% | 25 |
|
|
2016
Q2 | $1.3M | Sell |
35,115
-1,089
| -3% | -$40.3K | 1.11% | 24 |
|
|
2016
Q1 | $1.39M | Buy |
36,204
+1,005
| +3% | +$38.5K | 1.21% | 20 |
|
|
2015
Q4 | $1.78M | Buy |
35,199
+118
| +0.3% | +$5.96K | 1.59% | 8 |
|
|
2015
Q3 | $1.6M | Buy |
35,081
+2,695
| +8% | +$123K | 1.67% | 9 |
|
|
2015
Q2 | $1.89M | Buy |
32,386
+815
| +3% | +$47.6K | 1.78% | 4 |
|
|
2015
Q1 | $1.74M | Buy |
31,571
+584
| +2% | +$32.3K | 1.75% | 5 |
|
|
2014
Q4 | $1.56M | Buy |
+30,987
| New | +$1.56M | 1.64% | 5 |
|